Notably, mutations in the APOB gene may lead to elevated LDL levels and other lipid metabolic disorders as well as an increased risk of coronary heart disease owing to higher levels of serum APOB, even in the presence of normal levels of LDL (8-10). This evidence concerns the gene APOB and Disorder of lipid metabolism.